Stryker Femoral Heads Confidential Settlement A settlement was announced this month in the Strykler MDL litigation. The settlement covers individuals with cases in the federal court litigation  and cases filed in New Jersey state court who had revision surgery to replace the faulty LFIT CoCr V40 Femoral Head components in their hip implants. The faulty… Read More


Five plaintiffs were awarded a total of $502 million dollars in the 2nd test (bellwether) case to go to trial against Johnson & Johnson (J&J) relating to its Depuy Pinnacle hip implants, in January of 2016,  J&J appealed the verdict, which the trial judge reduced to $151 million dollars.  The 5th Circuit Court of Appeals heard oral argument on December 7, 2017, and issued their opinion  in April 2018. The Fifth Circuit overturned the entire verdict and remanded the case back to the Northern District of Texas and Judge Ed Kinkeade for a new trial.… Read More


Stryker Corporation has notified physicians and hospitals of an Urgent Medical Device Recall of its LFIT Anatomic Cobalt Chrome V39 femoral heads manufactured before 2011. Stryker received what it called a “higher than expected” number of reports from doctors of taper lock failure.… Read More


by Marilyn McGoldrick, Esq. Zimmer has announced a voluntary recall of its M/L Taper with Kinectiv Technology Femoral Stems and Necks used in hip replacements, because higher than expected amounts of manufacturing residues were left on the devices. Zimmer calls this a “process monitoring failure”; you’d probably call it not cleaning the parts properly before putting… Read More


Stryker Corp., the manufacturer of the recalled Rejuvenate and ABG II Modular Neck hip systems, announced this month that it is taking a $161 million dollar charge against its 2nd quarter earnings relating to the recall. Despite taking this charge, Stryker still reported making a $215 million dollar profit in the 2nd quarter on revenue of $2.35 billion.… Read More


Biomet, Inc. and counsel for Plaintiffs reached an agreement to settle all cases currently pending in the Biomet MDL (In Re Biomet M2A Magnum Hip Implant Products Liability Litigation, MDL 2391) and any future cases filed on or before April 15, 2014. To be eligible for compensation a plaintiff must have been implanted with a Biomet M2a 38 or M2A Magnum hip replacement system and underwent surgery to revise the device more than 180 days after it was implanted.… Read More


A second DePuy ASR hip implant case scheduled for trial this month has been resolved, according to court records. The lawsuit, MacDonald et al v. DePuy Orthopaedics Inc. et al, was filed in the Bergen County division of the New Jersey Superior Court and was scheduled to go to trial on October 21, 2013 before the Honorable Brian R. Martinotti. There are few details about the settlement available at this time and, as with prior Depuy hip settlements, the terms will likely remain confidential.

The lawsuit, MacDonald et al v. DePuy Orthopaedics Inc. et al, was filed in the Bergen County division of the New Jersey Superior Court and was scheduled to go to trial on October 21, 2013 before the Honorable Brian R. Martinotti. There are few details about the settlement available at this time and, as with prior Depuy hip settlements, the terms will likely remain confidential.… Read More


Posted by Thornton Law Firm LLP on Sep 3, 2013 5:58:00 AM The first bellwether trial in the federal court Multi-District Litigation over Johnson & Johnson’s DePuy Unit’s metal hip implants is scheduled to begin on Monday, September 9, 2013. The plaintiff is Ann McCracken, a woman from Rochester, New York who underwent a DePuy… Read More


As part of a recall affecting thousands of its metal-on-metal hips, Stryker has hired a third-party claims administrator, Broadspire Services, Inc., to evaluate claims for reimbursement of costs associated with its recalled hips. Stryker is offering to reimburse patients for testing, treatment, revision surgery and other costs associated to the recall.… Read More